SPOTLIGHT: Lilly loses bid to stop drug-reselling

A European court has ruled that Eli Lilly can't block a U.K. pharmacy from buying its meds in Turkey at cheaper prices and reselling them in the United States. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.